132 related articles for article (PubMed ID: 13528251)
1. [Spread of measles, chickenpox & mumps checked by a new method of prevention in a 200-bed sanatorium for children].
RUSTI J
Rev Immunol Ther Antimicrob; 1957; 21(5-6):393-6. PubMed ID: 13528251
[No Abstract] [Full Text] [Related]
2. [Experiences on protection against measles, mumps and chickenpox in larger child communities].
RUSTI G
Orv Hetil; 1958 Feb 2-Mar 23; 99(8-9):275-6. PubMed ID: 13553375
[No Abstract] [Full Text] [Related]
3. Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidelines for adults.
Hendriksz T; Malouf P; Foy JE;
J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S10-2. PubMed ID: 22086887
[TBL] [Abstract][Full Text] [Related]
4. [Polyvalent immunoglobulins in prevention of viral infections in children with neoplastic diseases treated with immunosuppressive therapy].
Graf N; Hille A; Jost W; Müller J
Padiatr Padol; 1991; 26(4):187-91. PubMed ID: 1749627
[TBL] [Abstract][Full Text] [Related]
5. [The need for changing the length of isolation and quarantine in cases of chickenpox, measles and mumps].
Biedrzycka R; Czubkowska I; Kurkus M; Szczepańiska H
Przegl Epidemiol; 1973; 27(1):85-95. PubMed ID: 4706679
[No Abstract] [Full Text] [Related]
6. Combination measles, mumps, rubella and varicella vaccine.
Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
[TBL] [Abstract][Full Text] [Related]
7. [Problems posed by measles, chickenpox and mumps in pregnancy].
Badillet M
Sem Hop; 1983 Feb; 59(5):314-8. PubMed ID: 6302861
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants.
Yerkovich ST; Rowe J; Richmond P; Suriyaarachchi D; Heaton T; Hollams E; Ladyman C; Serralha M; Sadowska A; Loh R; Wesselingh SL; Sly PD; Holt PG
Vaccine; 2007 Feb; 25(10):1764-70. PubMed ID: 17224218
[TBL] [Abstract][Full Text] [Related]
9. [Measles, mumps, rubella and varicella: antibody titration and vaccinations in a large hospital].
Cologni L; Belotti L; Bacis M; Moioli F; Goglio A; Mosconi G
G Ital Med Lav Ergon; 2012; 34(3 Suppl):272-4. PubMed ID: 23405639
[TBL] [Abstract][Full Text] [Related]
10. [Initial results and evaluation of igg antibody levels for measles, mumps, rubella and chickenpox viruses in young adults born in 1989].
Sadowska-Galera M
Przegl Epidemiol; 2009; 63(3):363-7. PubMed ID: 19899592
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
Buxbaum S; Doerr HW; Allwinn R
Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
[TBL] [Abstract][Full Text] [Related]
12. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
13. Long-term epidemiologic longitudinal study on the effect of vaccines on public inoculation.
Matsuoka I; Matsuoka T; Matsuoka A; Shigemura T; Agematsu K; Koike K
Turk J Pediatr; 2012; 54(4):376-81. PubMed ID: 23692718
[TBL] [Abstract][Full Text] [Related]
14. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
Shinefield HR; Black S; Kuter BJ
J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
[TBL] [Abstract][Full Text] [Related]
15. Vaccines in dermatological diseases.
Magel GD; Mendoza N; Digiorgio CM; Haitz KA; Lapolla WJ; Tyring SK
G Ital Dermatol Venereol; 2011 Jun; 146(3):225-33. PubMed ID: 21566552
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
17. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
[TBL] [Abstract][Full Text] [Related]
18. Communicable diseases and immunizations.
Cranston L
Can Nurse; 1976 Jan; 72(1):34-40. PubMed ID: 1253141
[No Abstract] [Full Text] [Related]
19. Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad(®)) in infants from 9 months of age.
Vesikari T; Becker T; Gajdos V; Fiquet A; Thomas S; Richard P; Baudin M
Vaccine; 2012 Apr; 30(20):3082-9. PubMed ID: 22406278
[TBL] [Abstract][Full Text] [Related]
20. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
Ramet J
Int J Infect Dis; 2007 Nov; 11 Suppl 2():S49-55. PubMed ID: 18162247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
